Butylated Hydroxytoluene vs Caramel Color IV: which is worse?

What is Butylated Hydroxytoluene?

Butylated hydroxytoluene (BHT) is a synthetic phenolic antioxidant preservative derived from petroleum. A white crystalline solid with formula C15H24O, it prevents fat oxidation in processed foods, cosmetics, and industrial applications. Often used synergistically with BHA.

What is Caramel Color IV?

Caramel Color IV (Class IV caramel, E150d) is a food coloring made by heating sugar with both ammonium and sulfite compounds. This production method creates a unique set of reactive byproducts, notably 4-methylimidazole (4-MEI), which has been linked to cancer in animal studies. It is the most widely used caramel coloring in beverages like Coca-Cola and Pepsi.

Documented risks

Butylated Hydroxytoluene: BHT has complex, bidirectional carcinogenicity data — some NTP bioassays found liver tumors in female mice at high doses, while other studies suggested BHT might inhibit cancer initiation. IARC has not formally classified BHT due to conflicting evidence. A 2017 study linked BHT to thyroid hormone disruption in female rats. The American Academy of Pediatrics (2018) recommended reducing synthetic preservative exposure including BHT in children. Kellogg's uses vitamin E in European versions of cereals that contain BHT in US versions — a commercially meaningful substitution.

Caramel Color IV: The primary concern with Caramel Color IV is 4-methylimidazole (4-MEI), a byproduct of the ammonia-sulfite caramel production process. The National Toxicology Program (NTP) found that 4-MEI caused lung cancer in male and female mice at high doses in 2-year bioassay studies, leading to California listing 4-MEI as a known carcinogen under Proposition 65 in 2011. The Prop 65 safe harbor level is 29 micrograms 4-MEI per day (the level that would cause 1 additional cancer per 100,000 people over a 70-year lifetime). CSPI testing in 2011-2012 found Coca-Cola and Pepsi sold in California contained 4-MEI levels that, at typical consumption rates, would exceed this threshold — triggering voluntary reformulation by both companies to reduce 4-MEI in their US products. The FDA reviewed 4-MEI and concluded that typical exposure levels 'are not a safety concern.' EFSA's evaluation found the NTP findings concerning but noted the margin of safety at typical European exposure levels. The cancer mechanism in mice involves high doses that may not extrapolate to typical human cola consumption.